Page last updated: 2024-11-04

sulfasalazine and Retinal Artery Occlusion

sulfasalazine has been researched along with Retinal Artery Occlusion in 1 studies

Sulfasalazine: A drug that is used in the management of inflammatory bowel diseases. Its activity is generally considered to lie in its metabolic breakdown product, 5-aminosalicylic acid (see MESALAMINE) released in the colon. (From Martindale, The Extra Pharmacopoeia, 30th ed, p907)
sulfasalazine : An azobenzene consisting of diphenyldiazene having a carboxy substituent at the 4-position, a hydroxy substituent at the 3-position and a 2-pyridylaminosulphonyl substituent at the 4'-position.

Retinal Artery Occlusion: Sudden ISCHEMIA in the RETINA due to blocked blood flow through the CENTRAL RETINAL ARTERY or its branches leading to sudden complete or partial loss of vision, respectively, in the eye.

Research Excerpts

ExcerptRelevanceReference
"Retinal neovascularization was detected during the follow-up."1.31Unilateral retinal vasculitis, branch retinal artery occlusion and subsequent retinal neovascularization in Crohn's disease. ( Durak, I; Ergin, MH; Koçak, N; Saatci, OA, 2001)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Saatci, OA1
Koçak, N1
Durak, I1
Ergin, MH1

Other Studies

1 other study available for sulfasalazine and Retinal Artery Occlusion

ArticleYear
Unilateral retinal vasculitis, branch retinal artery occlusion and subsequent retinal neovascularization in Crohn's disease.
    International ophthalmology, 2001, Volume: 24, Issue:2

    Topics: Adult; Anti-Inflammatory Agents; Crohn Disease; Diagnostic Techniques, Ophthalmological; Drug Combin

2001